支气管扩张患者高分辨CT Bhalla评分与肺功能的相关性研究被引量：5

Correlation between Bhalla score of high resolution computed tomography and pulmonary function in bronchiectasis

在线阅读下载PDF

导出

摘要目的研究支气管扩张患者高分辨CT(HRCT)Bhalla评分与肺功能的相关性。方法收集63例稳定期支气管扩张患者,完善肺功能检查,由2位影像科医师阅片行HRCT Bhalla评分,与肺功能进行相关性分析。结果支气管扩张患者肺功能为用力肺活量占预计值百分比(FVC%pred)[(84.5±22.5)%],第1秒用力呼气容积占预计值百分比(FEV1%pred)[(68.0±29.4)%],第1秒用力呼气容积/用力肺活量(FEV1/FVC)[(62.1±15.8)%],支气管扩张患者HRCT Bhalla评分为(14.30±4.58)分。Bhalla评分与FVC%pred、FEV1%pred、FEV1/FVC%之间存在正相关性,差异有统计学意义(FVC%pred,P=0.01;FEV1%pred,P<0.01;FEV1/FVC/%,P<0.01)。结论 HRCT Bhalla评分与肺功能有良好的相关性,可以帮助评价肺结构的变化。 Objective To investigate the correlation between Bhalla score of high resolution computed tomography (HRCT)and pulmonary function in bronchiectasis.Methods All the 63 enrolled patients with stable bronchiectasis were conducted the pulmonary function,two radiologists evaluated the Bhalla score,then the correlation between Bhalla score and pulmonary function was analyzed.Results The results of pulmonary function were FVC% pred [(84.5 ± 22.5) % ],FEV1% pred [(68.0 ±29.4) % ],FEV1/FVC [(62.1 ± 15.8)%].There was positive correlation between Bhalla score and pulmonary function (FVC% pred,P = 0.01; FEV1% pred,P < 0.01; FEV1/FVC/%,P < 0.01).Conclusion The Bhalla score represents a positive correlation with spirometry and can be an ally in the evaluation of pulmonary structural changes.

作者崔娟娟殷克勤王利孙向东刘绍霞

机构地区郑州大学第一附属医院呼吸内科

出处《河南医学研究》 CAS 2017年第20期3656-3658,共3页 Henan Medical Research

关键词支气管扩张高分辨CT Bhalla评分肺功能 bronchiectasis HRCT bhalla score pulmonary function

分类号 R562.22 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献1

1无,何权瀛.成人支气管扩张症诊治专家共识[J].中华结核和呼吸杂志,2012,35(7):485-492. 被引量：459

二级参考文献18

1Woodhead M, Blasi F, Ewig S, et al. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J,2005,26 : 1138-1180.
2Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections - - full version. Clin Microbiol Infect, 2011, 17 Suppl 6: El-E59.
3Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax,2010,65 Suppl 1 :i1- 58.
4Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Am J Respir Cfit Care Med, 2004,169 : A330.
5Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child,2005, 90:737-740.
6Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Clin Pulm M ed,2005,12:205- 209.
7Crofton J. Bronchiectasis. In: Cmflon J, Douglas A, eds. Respiratory diseases. 3 rd eds. Oxford: Blackwell Scientific, 1981:417-430.
8Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004,70 : 400- 407.
9O'Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax, 2000,55 : 635-642.
10King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis, 2009,4 : 411-419.